We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Postsynaptic Density Genes Linked to Multitude of Brain Disorders

By LabMedica International staff writers
Posted on 29 Dec 2010
Print article
The postsynaptic density (PSD), an enigmatic structure located in some brain cell synapses, was analyzed at the proteomic and genomic levels and found to be the source of proteins involved in more than 130 brain diseases.

The PSD is a physical feature of the cytoskeleton found in some synapses of brain cells. PSDs were originally identified by electron microscopy as an electron-dense region at the membrane of a postsynaptic neuron. A PSD's molecular scaffolding is usually composed of L-glutamate neurotransmitter receptors. PSDs also contain cell adhesion molecules and a diverse set of other signaling proteins. PSDs vary in size and composition among brain regions, varying in size from about 250 nm to 500 nm in diameter and 25 nm to 50 nm in thickness, depending on the activity state of the synapse.

In the current study, investigators at the Wellcome Trust Sanger Institute (Hinxton, United Kingdom) isolated the postsynaptic density from human neocortex (hPSD) from patients undergoing brain surgery. The material was examined at both the genomic and proteomic levels. Results published in the December 19, 2010, online edition of the journal Nature Neuroscience revealed that the investigators had identified 1,461 distinct proteins. Mutations among the genes coding for these proteins were linked to 133 neurological and psychiatric diseases.

"We found over 130 brain diseases involve the PSD -- far more than expected," said senior author Dr. Seth Grant, a principle investigator at the Wellcome Trust Sanger Institute. "The human PSD is at center stage of a large range of human diseases affecting millions of people. The conservation of the structure of these proteins suggests that the behaviors governed by the PSD and the diseases associated with them have not changed much over many millions of years."

"We can also see ways to develop new genetic diagnostic tests and help doctors classify the brain diseases," said Dr. Grant.

In an effort to boost PSD research, the investigators have created and released into the public domain a "molecular roadmap" for human synapses showing how the 1,461 proteins and the 130 diseases interconnect.

Related Links:
Wellcome Trust Sanger Institute


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Automated Blood Typing System
IH-500 NEXT
New
Automated Nucleic Acid Extractor
eLab
New
Progesterone Serum Assay
Progesterone ELISA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The artificial intelligence models can personalize immune therapies in oncology patients (Photo courtesy of 123RF)

AI Tool Identifies Novel Genetic Signatures to Personalize Cancer Therapies

Lung cancer and bladder cancer are among the most commonly diagnosed cancers globally. Researchers have now developed artificial intelligence (AI) models designed to personalize immune therapies for oncology... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.